An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.
An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.
复制标题
DOI：
10.1016/j.yhbeh.2017.11.015
复制
发表时间：
2018-03
影响因子：
3.5
通讯作者：
Prokai L
中科院分区：
文献类型：
--
作者：
Tschiffely AE;Schuh RA;Prokai-Tatrai K;Ottinger MA;Prokai L
Estrogens are neuroprotective, and studies suggest that they may mitigate the pathology and symptoms of Alzheimer’s disease (AD) in female models. However, central estrogen effects have not been examined in males in the context of AD. The purpose of this follow-up study was to assess the benefits of a brain-selective 17β-estradiol estrogen prodrug, 10β,17β-hydroxyestra-1,4-dien-3-one (DHED), also in the male APPswe/PS1dE9 double transgenic mouse model of the disease. After continuously exposing 6-month old animals to DHED for two months, their brains showed decreased amyloid precursor and amyloid-β protein levels. The DHED-treated APPswe/PS1dE9 double transgenic subjects also exhibited enhanced performance in a cognitive task, while 17β-estradiol treatment did not reach statistical significance. Taken together, data presented here suggest that DHED may also have therapeutic benefit in males and warrant further investigations to fully elucidate the potential of targeted estrogen therapy for a gender-independent treatment of early-stage AD.
登录
查看更多内容
影响因子：
3.3
作者：
Barker, J. M.;Galea, L. A. M.
通讯作者：
Galea, L. A. M.
影响因子：
3.5
作者：
Carter, Christine L.;Resnick, Eileen M.;Kalbarczyk, Anna
通讯作者：
Kalbarczyk, Anna
影响因子：
14.8
作者：
Alamed, Jennifer;Wilcock, Donna M.;Morgan, Dave
通讯作者：
Morgan, Dave
影响因子：
2.6
作者：
Davey, Dennis A.
通讯作者：
Davey, Dennis A.
影响因子：
17.1
作者：
Prokai L;Nguyen V;Szarka S;Garg P;Sabnis G;Bimonte-Nelson HA;McLaughlin KJ;Talboom JS;Conrad CD;Shughrue PJ;Gould TD;Brodie A;Merchenthaler I;Koulen P;Prokai-Tatrai K
通讯作者：
Prokai-Tatrai K